Evidence map›Paper›PMID 38689693›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2024

Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series.

Christophe Masset, Claire Garandeau, Simon Ville, Magali Giral, Aurélie Houzet, Julien Branchereau, Ismaël Chelghaf, Benoit Mesnard, Gilles Blancho, Jacques Dantal and 1 more

Abstract readLetter
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christophe MassetInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Claire GarandeauInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Simon VilleInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Magali GiralInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Aurélie HouzetInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Julien BranchereauInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Ismaël ChelghafInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Benoit MesnardInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Gilles BlanchoInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Jacques DantalInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Diego CantarovichInstitut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AbataceptImmunosuppressive AgentsPancreas TransplantationAdultCohort StudiesFemaleGraft RejectionGraft SurvivalHumansMaleMiddle AgedRetrospective StudiesAbataceptImmunosuppressive Agentsbelatacept conversioncalcineurin inhibitor toxicitypancreas allograft functionpancreas transplantationrejection

Identifiers

PMID38689693
PMCPMC11058835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.